InvestorsHub Logo

Medtrade77

12/30/19 10:36 AM

#19363 RE: plinter1 #19362

I heard they presented at an industry roundtable weeks ago. Many are fearing the used scanner market is exhausted.
To the best of my knowledge only Positron has new PET scanners. Even better is their scanner works with new software technology that makes it the only choice in cardiac imaging.
IMO Physicians know such facts and are planing their next move.

zenvesting

12/30/19 3:11 PM

#19364 RE: plinter1 #19362

I would say some inexperienced investors/traders (perhaps doctors) are making the stock go crazy because they are excited about what is going on in the industry and they want in because they the know the company is well positioned to capitalize on the emerging industry trends.

This article does a nice job of summarizing why the industry trends are going to be creating a favorable playing field for PET scanning in general, and Positron Corp. in particular:
https://www.dicardiology.com/article/6-trends-cardiac-nuclear-imaging-asnc-2019-meeting

"Forget FFR-CT, do PET studies and you may get a better result," Mahmarian said. "I think the future of nuclear imaging is bright."
.....
Beanlands said there also is increasing interest in PET imaging because of its superior image quality, speed of the exam and increasing access to PET radiotracers. New tracers on the horizon also will increase the image quality and flexibility of PET to accommodate exercise stress. He said single photon emission computed tomography (SPECT) has been the standard for cardiac nuclear imaging for decades, but PET offers improved image quality for more precise diagnosis.
.....
Flurpiridaz F-18 PET perfusion agent that offers high quality images and can be used with exercise stress;

Even with the ask at a $1, I didn't put in any sell orders, I do think this has potential to be worth more in a few years as these industry trends play out.